X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 21,268 | 29,055 | 19,119 | 18,997 | 17,936 |
| Operating Income | -21,268 | -29,055 | -19,119 | -18,997 | -17,936 |
| Interest Expense | 913 | 926 | 920 | 905 | 891 |
| Other Income | 239 | -223 | -134 | 270 | 157 |
| Pre-tax Income | -21,942 | -30,204 | -20,173 | -19,632 | -18,670 |
| Income Tax | 23 | 3 | 2 | 6 | 6 |
| Net Income Continuous | -21,965 | -30,207 | -20,175 | -19,638 | -18,676 |
| Net Income | $-21,965 | $-30,207 | $-20,175 | $-19,638 | $-18,676 |
| EPS Basic Total Ops | -21.62 | -35.74 | -22.82 | -22.22 | -39.04 |
| EPS Basic Continuous Ops | -19.55 | -31.42 | -22.77 | -22.23 | -27.03 |
| EPS Diluted Total Ops | -21.62 | -35.74 | -22.82 | -22.22 | -39.04 |
| EPS Diluted Continuous Ops | -19.55 | -31.42 | -22.77 | -22.23 | -27.03 |
| EBITDA(a) | $-21,135 | $-19,165 | $-18,987 | $-18,868 | $-17,830 |